Beurs gesloten -
Bombay S.E.
12:11:13 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
813,9
INR
|
+8,21%
|
|
+1,43%
|
+23,86%
|
Fiscaal tijdperk: Maart |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
56.215
|
48.141
|
99.854
|
-
|
-
|
Bedrijfswaarde
1 |
51.123
|
45.047
|
95.161
|
99.854
|
99.854
|
K/w-verhouding
|
12,9
x
|
10,3
x
|
20,2
x
|
18,2
x
|
15,9
x
|
Dividendrendement
|
2,29%
|
5,34%
|
2,59%
|
2,95%
|
3,08%
|
Marktkapitalisatie/omzet
|
2,63
x
|
2,23
x
|
4,17
x
|
3,87
x
|
3,38
x
|
Bedrijfswaarde/omzet
|
2,39
x
|
2,08
x
|
4,17
x
|
3,87
x
|
3,38
x
|
Bedrijfswaarde/EBITDA
|
8,1
x
|
7,01
x
|
14,1
x
|
12,7
x
|
10,9
x
|
Bedrijfswaarde/FCF
|
11,3
x
|
31,5
x
|
31,5
x
|
46,9
x
|
39,5
x
|
FCF Yield
|
8,85%
|
3,18%
|
3,17%
|
2,13%
|
2,53%
|
Price to Book
|
-
|
2,25
x
|
4,03
x
|
3,54
x
|
3,03
x
|
Aantal aandelen (in duizenden)
|
122.527
|
122.527
|
122.527
|
-
|
-
|
Referentieprijs
2 |
458,8
|
392,9
|
815,0
|
815,0
|
815,0
|
Datum van publicatie
|
20-04-22
|
27-04-23
|
25-04-24
|
-
|
-
|
Fiscaal tijdperk: Maart |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
18.852
|
21.379
|
21.612
|
22.832
|
25.787
|
29.542
|
EBITDA
1 |
-
|
6.308
|
6.423
|
6.742
|
7.887
|
9.120
|
Bedrijfsresultaat (EBIT)
1 |
-
|
5.929
|
6.002
|
6.208
|
7.339
|
8.414
|
Operationele Marge
|
-
|
27,73%
|
27,77%
|
27,19%
|
28,46%
|
28,48%
|
Resultaat voor belastingen (EBT)
1 |
-
|
5.649
|
6.286
|
6.313
|
7.517
|
8.489
|
Nettowinst (verlies)
1 |
-
|
4.187
|
4.670
|
4.709
|
5.504
|
6.307
|
Nettomarge
|
-
|
19,59%
|
21,61%
|
20,62%
|
21,35%
|
21,35%
|
WPA
2 |
-
|
35,63
|
38,11
|
38,38
|
44,87
|
51,41
|
Free Cash Flow
1 |
-
|
4.524
|
1.432
|
3.056
|
2.127
|
2.525
|
FCF-marge
|
-
|
21,16%
|
6,63%
|
12,78%
|
8,25%
|
8,55%
|
Kasstroomconversie (ebitda)
|
-
|
71,73%
|
22,3%
|
41,56%
|
26,97%
|
27,69%
|
Kasstroomconversie (nettowinst)
|
-
|
108,05%
|
30,67%
|
58,63%
|
38,64%
|
40,04%
|
Dividend per aandeel
2 |
-
|
10,50
|
21,00
|
21,10
|
24,07
|
25,07
|
Datum van publicatie
|
20-07-21
|
20-04-22
|
27-04-23
|
25-04-24
|
-
|
-
|
Fiscaal tijdperk: Maart |
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Omzet
1 |
5.638
|
5.260
|
5.192
|
4.994
|
5.093
|
5.407
|
6.213
|
5.784
|
5.980
|
6.025
|
6.070
|
EBITDA
1 |
-
|
1.496
|
-
|
1.468
|
1.436
|
1.455
|
2.064
|
1.932
|
2.012
|
1.693
|
1.702
|
Bedrijfsresultaat (EBIT)
1 |
1.598
|
1.399
|
1.378
|
1.464
|
1.437
|
1.413
|
1.949
|
1.824
|
1.947
|
-
|
1.708
|
Operationele Marge
|
28,33%
|
26,59%
|
26,53%
|
29,31%
|
28,22%
|
26,13%
|
31,37%
|
31,53%
|
32,56%
|
-
|
28,14%
|
Resultaat voor belastingen (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1.820
|
-
|
-
|
1.729
|
Nettowinst (verlies)
1 |
-
|
1.037
|
-
|
1.087
|
1.069
|
1.050
|
1.464
|
1.354
|
1.419
|
1.182
|
1.176
|
Nettomarge
|
-
|
19,72%
|
-
|
21,77%
|
20,99%
|
19,42%
|
23,56%
|
23,42%
|
23,73%
|
19,62%
|
19,36%
|
WPA
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
11,05
|
-
|
-
|
10,40
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
10-11-21
|
08-02-22
|
20-04-22
|
04-08-22
|
21-10-22
|
27-01-23
|
27-04-23
|
21-07-23
|
-
|
-
|
-
|
Fiscaal tijdperk: Maart |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
-
|
5.093
|
3.094
|
3.498
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
4.524
|
1.432
|
3.056
|
2.127
|
2.525
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
29,8%
|
22,3%
|
22,7%
|
21,9%
|
21,9%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
2 |
-
|
-
|
175,0
|
202,0
|
230,0
|
269,0
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
1.452
|
1.702
|
1.606
|
3.333
|
2.833
|
Capex/omzet
|
-
|
6,79%
|
7,87%
|
6,72%
|
12,93%
|
9,59%
|
Datum van publicatie
|
20-07-21
|
20-04-22
|
27-04-23
|
25-04-24
|
-
|
-
|
Laatste slotkoers
815
INR Gemiddelde koersdoel
905,8
INR Spread / Gemiddelde doel +11,14% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +25,83% | 661 mld. | | +27,00% | 566 mld. | | -6,76% | 352 mld. | | +20,34% | 332 mld. | | +3,00% | 283 mld. | | +13,09% | 231 mld. | | +5,46% | 200 mld. | | -9,61% | 195 mld. | | -6,26% | 145 mld. |
Farmaceutische producten - Andere
|